The largest database of trusted experimental protocols

Fvb and 129 e mice

Manufactured by Charles River Laboratories

FVB and 129-E mice are inbred laboratory mouse strains commonly used in research. FVB mice are characterized by their high reproductive performance and large pronuclei, making them suitable for microinjection studies. The 129-E strain is known for its embryonic stem cell derivation and is often used in gene targeting experiments. Both strains provide reliable and standardized model organisms for various scientific investigations.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using fvb and 129 e mice

1

Murine Tumor Implantation and Immunotherapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
FVB and 129-E mice were purchased from Charles River Laboratories. Tumor cells were implanted in 7–9-week-old mice subcutaneously at optimal doses as indicated in figure legends. Tumor length and width were measured by caliper and the volume calculated by the equation: 0.4 × length × width2. For bioluminescence studies, images were obtained with the IVIS Spectrum imager after intraperitoneal (IP) injection of d-luciferin (150 mg/kg). For immunotherapy studies, mice bearing ~ 50 mm3 tumors were randomized and treated with 200 μg of anti-PD-1 antibody (BioXcell, Clone RMP1-14) or isotype control via IP injections three times weekly for four doses. Mice were housed in pathogen-free facilities at UCLA and all procedures were approved by the UCLA Animal Research Committee.
+ Open protocol
+ Expand
2

Murine Tumor Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
FVB and 129-E mice were purchased from Charles River Laboratories. Tumor cells were implanted in 7–9-week-old mice subcutaneously at optimal doses as indicated in figure legends. Tumor length and width were measured by caliper and the volume calculated by the equation: 0.4 × length × width2. For bioluminescence studies, images were obtained with the IVIS Spectrum imager after intraperitoneal (IP) injection of D-luciferin (150 mg/kg). For immunotherapy studies, mice bearing ∼ 50 mm3 tumors were randomized and treated with 200 μg of anti-PD-1 antibody (BioXcell, Clone RMP1–14) or isotype control via IP injections three times weekly for four doses. Mice were housed in pathogen-free facilities at UCLA and all procedures were approved by the UCLA Animal Research Committee.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!